Entera Bio
ENTX
12 hedge funds and large institutions have $2.17M invested in Entera Bio in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
33% more funds holding
Funds holding: 9 → 12 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.91% less ownership
Funds ownership: 9.83% → 8.92% (-0.91%)
34% less capital invested
Capital invested by funds: $3.28M → $2.17M (-$1.12M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$22.6K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$10.1K |
| 3 |
Renaissance Technologies
New York
|
+$4.87K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$640 |
| 5 |
Morgan Stanley
New York
|
+$85 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$343K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$7.41K |
| 3 |
JP Morgan Chase
New York
|
-$2K |
ENTX Hedge Fund Activity: Q2 2023 in Review
12 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q2 2023, worth a combined $2.17M — down 34% from $3.28M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ENTX positions and 2 closed out — a net gain of 3 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $22.6K. The largest seller was RA Capital Management, exiting entirely with an estimated $343K sold.
- 12 institutional investors held Entera Bio (ENTX) as of Q2 2023, up from 9 in Q1 2023.
- Funds reported $2.17M of Entera Bio stock for Q2 2023, down 34% quarter-over-quarter.
- 5 funds opened new Entera Bio positions in Q2 2023 and 2 closed out, a net change of +3 holders.
- The largest Entera Bio buyer in Q2 2023 was HRT Financial, an estimated $22.6K added.
- The largest Entera Bio seller in Q2 2023 was RA Capital Management, an estimated $343K sold.
Based on aggregated 13F filings for Q2 2023.